polypeptide mediator cystic fibrosis pp 25971 although complex model involving multiple locus may plausible high frequency cystic fibrosis caucasian probably best explained selective advantage heterozygote carrier short analogy cystic fibrosis hemoglobin sickle cell anemia may greater taysachs disease term molecular mechanism protein polypeptide difference reported humoral fluid cystic fibrosis patient heterozygotic relative connected selected bioassay system direction relate model proposed intermediate stage physiology cystic fibrosis build large body elegant experimental work basic tenet cell cystic fibrosis heterozygote normal individual stimulatory loop chronic reserpine treatment exaggerates normal rat loop similar one exaggerated genetic difference human elevating pathological level otherwise normal process